Enrique A. Conterno, SVP&Pres, Lilly Diab & Lilly USA at LILLY ELI & CO (LLY), sold 25,000 shares at $85.00 ($2.1M) on 2018-05-31, disclosed to the SEC on 2018-06-01.
Open-market sale of $2.1M LLY by SVP&Pres, Lilly Diab & Lilly USA. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FGEN | SELL | 2023-04-11 | $36K | — | Filing → |
| FGEN | SELL | 2023-03-23 | $787K | — | Filing → |
| FGEN | SELL | 2023-03-10 | $1.7M | — | Filing → |